A female infant with thanatophoric dysplasia was found to have a de novo translocation involving chromosomes 1 and 10. The chromosome abnormality may represent an important clue in identifying the locus for the candidate gene responsible for this lethal skeletal dysplasia. (JMed Genet 1995;32:293-295) Thanatophoric dysplasia (TD) is the most common lethal skeletal dysplasia with a livebirth prevalence estimated to be between 0-28 and 0 6/10 000.2 Clinically affected infants have marked limb shortening and a small thorax, and death usually occurs in the neonatal period as a result of pulmonary hypoplasia. However, survival into childhood occurs rarely.3 Two forms of TD are felt to exist.4 In type 1, there are curved, long tubular bones, especially the femora, very flat vertebral bodies, and usually no evidence of a cloverleaf skull. In type 2, the femora are straight, platyspondyly is milder, and a cloverleaf skull is usually present.
Thanatophoric dysplasia (TD) is the most common lethal skeletal dysplasia with a livebirth prevalence estimated to be between 0-28 and 0 6/10 000.2 Clinically affected infants have marked limb shortening and a small thorax, and death usually occurs in the neonatal period as a result of pulmonary hypoplasia. However, survival into childhood occurs rarely.3 Two forms of TD are felt to exist.4 In type 1, there are curved, long tubular bones, especially the femora, very flat vertebral bodies, and usually no evidence of a cloverleaf skull. In type 2, the femora are straight, platyspondyly is milder, and a cloverleaf skull is usually present.
Histopathologically, the growth plate in TD is interrupted by tufts of ossifying tissue, exhibiting features of both endochondral and membranous ossification. 5 TD is thought to be transmitted in an autosomal dominant fashion.5 Since most cases of TD are sporadic, its occurrence in an infant is presumed to be the result of a new autosomal dominant mutation. 6 We report the first case of TD in which an apparent de novo balanced reciprocal translocation was present in the affected infant.
Case report A white female, who was the second of twins, was born at 36 weeks' gestation to a 29 year old G2P 1 woman and her 36 year old husband. Both had normal stature and there was no consanguinity. In the second trimester, on ultrasound, severe limb shortening, a small thorax, and polyhydramnios were detected in one fetus, with no abnormalities noted in the other fetus. After caesarean section, the infant had marked limb shortening, a small thorax, brachydactyly, macrocephaly without a clover- triplets,'0 presumably resulting from a new autosomal dominant mutation, absence of parental consanguinity, possible paternal age effect, and high new mutation rate.6 The finding of TD with cloverleaf skull in sibs who were the products of normal, non-consanguineous parents'1 probably reflects germline mosaicism rather than autosomal recessive inheritance.
To date, the genes responsible for TD type 1 and TD type 2 have not been mapped. We speculate that the presence of a de novo chromosomal rearrangement in our case may represent an important clue in identifying the locus for the candidate gene responsible for TD type 1. An increased risk for mental retardation and congenital anomalies is known to be directly related to the presence of a de novo balanced structural rearrangement.'2 This association is thought to develop as a result of a number of different mechanisms. These include the presence of an unbalanced translocation not detected cytogenetically, no loss of chromosomal material, but the translocation breakpoint occurs within the gene, leading to abnormal or absent gene function, or, finally, no chromosomal loss, but a new arrangement of genetic material leading to abnormal gene function.'2 The presence of an apparent balanced, reciprocal translocation in a patient with a known genetic disorder has proven to be valuable in the localisation of the disease gene in a number of conditions, for example, Duchenne muscular dystrophy.'2 In the case of our patient, the chromosomal rearrangement also appeared to be balanced. Therefore, we speculate that the translocation resulted in a gene mutation associated with an alteration or loss of gene function leading to an abnormal phenotype. However, we have been unable to find a relationship between the genes currently mapped to both regions of the chromosomal translocation breakpoints discovered in our patient and the pathogenesis of this skeletal dysplasia.
Chromosomal translocations provide a critical entry point for discovering the gene locus of a genetic disorder by using positional cloning methods. The chromosomal abnormality in our patient is the first to be described in TD. This finding, therefore, may represent the initial step in identifying the gene responsible for this condition, and providing information to determine whether TD type 1 and TD type 2 are genetically distinct entities, with overlapping features.
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to the locus of the candidate gene.
